Peter Hersey Professor in Melanoma Biology, University of Sydney, Australia.
Professor Peter Hersey is a graduate of the University of Adelaide. He completed a PhD on tumor immunology in the university of Oxford and has been involved in melanoma research and treatment firstly as a research fellow and then from positions as staff specialist in Sydney hospital and Mater hospital in Newcastle. He held postions of Research director at the Newcastle melanoma unit and Conjoint professor of Oncology in the University of Newcastle before taking up the inaugural chair of Melanoma Biology in the University of Sydney in 2011. His translational research activities have involved phase I-III trials in melanoma including conduct of a large phase III trial of immunotherapy in melanoma, use of modified peptide antigens and other melanoma vaccines using of dendritic cell vaccines. He has taken a leading role in studies on properties of melanoma cells that make them resistant to treatment and new treatment approaches to overcome these properties. He is generally recognized as a pioneer of immunotherapy for melanoma in Australia and in focusing on properties of melanoma cells that make them resistant to therapies. He has participated in most of the key clinical trials on immunotherapy with immune checkpoint inhibitors. He has published over 320 peer reviewed papers and is a joint holder of a NHMRC program grant since 2005 which has been renewed for a third 5 year period.